UHMK1 promotes lung adenocarcinoma oncogenesis by regulating the PI3K/AKT/mTOR signaling pathway

BACKGROUND: Effective targeted therapy for lung adenocarcinoma (LUAD), the number one cancer killer worldwide, continues to be a difficult problem because of the limitation of number of applicable patients and acquired resistance. Identifying more promising drug targets for LUAD treatment holds imme...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yongmeng, Wang, Shuai, Jin, Kai, Jin, Wenxing, Si, Libo, Zhang, Huiying, Tian, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125785/
https://www.ncbi.nlm.nih.gov/pubmed/36919755
http://dx.doi.org/10.1111/1759-7714.14850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125785/
https://www.ncbi.nlm.nih.gov/pubmed/36919755
http://dx.doi.org/10.1111/1759-7714.14850

Ejemplares similares